- Home
- Publications
- Publication Search
- Publication Details
Title
EF24 induces ferroptosis in osteosarcoma cells through HMOX1
Authors
Keywords
EF24, HMOX1, Ferroptosis, Osteosarcoma
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 136, Issue -, Pages 111202
Publisher
Elsevier BV
Online
2021-01-15
DOI
10.1016/j.biopha.2020.111202
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
- (2019) Sigbjørn Smeland et al. EUROPEAN JOURNAL OF CANCER
- Curcumin reduces renal damage associated with rhabdomyolysis by decreasing ferroptosis-mediated cell death
- (2019) Melania Guerrero-Hue et al. FASEB JOURNAL
- ATF6α Activation Enhances Survival against Chemotherapy and Serves as a Prognostic Indicator in Osteosarcoma
- (2019) Suma Yarapureddy et al. NEOPLASIA
- Lysosomal Destabilizing Drug Siramesine and the Dual Tyrosine Kinase Inhibitor Lapatinib Induce a Synergistic Ferroptosis through Reduced Heme Oxygenase-1 (HO-1) Levels
- (2019) Gloria E. Villalpando-Rodriguez et al. Oxidative Medicine and Cellular Longevity
- Piperlongumine analogue L50377 induces pyroptosis via ROS mediated NF-κB suppression in non-small-cell lung cancer
- (2019) Qian Li et al. CHEMICO-BIOLOGICAL INTERACTIONS
- AR ubiquitination induced by the curcumin analog suppresses growth of temozolomide-resistant glioblastoma through disrupting GPX4-Mediated redox homeostasis
- (2019) Tzu-Chi Chen et al. Redox Biology
- Heme oxygenase-1 mediates BAY 11–7085 induced ferroptosis
- (2018) Ling-Chu Chang et al. CANCER LETTERS
- Synthesis and anti-tumor activity of EF24 analogues as IKKβ inhibitors
- (2018) Rong Jin et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Unconventional Ways to Live and Die: Cell Death and Survival in Development, Homeostasis, and Disease
- (2018) Swapna A. Gudipaty et al. Annual Review of Cell and Developmental Biology
- A Dual Role of Heme Oxygenase-1 in Cancer Cells
- (2018) Shih-Kai Chiang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Bioactivities of EF24, a Novel Curcumin Analog: A Review
- (2018) Yonghan He et al. Frontiers in Oncology
- Design, synthesis, and evaluation of asymmetric EF24 analogues as potential anti-cancer agents for lung cancer
- (2017) Jianzhang Wu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- miR-491 Inhibits Osteosarcoma Lung Metastasis and Chemoresistance by Targeting αB-crystallin
- (2017) Shu-Nan Wang et al. MOLECULAR THERAPY
- Germline and somatic genetics of osteosarcoma — connecting aetiology, biology and therapy
- (2017) D. Matthew Gianferante et al. Nature Reviews Endocrinology
- MicroRNA-140-5p regulates osteosarcoma chemoresistance by targeting HMGN5 and autophagy
- (2017) Yichen Meng et al. Scientific Reports
- GFRA1 promotes cisplatin-induced chemoresistance in osteosarcoma by inducing autophagy
- (2016) Mihwa Kim et al. Autophagy
- Ferroptosis: process and function
- (2016) Y Xie et al. CELL DEATH AND DIFFERENTIATION
- Recent Advances in Mechanobiology of Osteosarcoma
- (2016) Christos Adamopoulos et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Prognostic value of inflammation-based scores in patients with osteosarcoma
- (2016) Bangjian Liu et al. Scientific Reports
- Regulation of Ferroptotic Cancer Cell Death by GPX4
- (2014) Wan Seok Yang et al. CELL
- Induction of apoptosis by diphenyldifluoroketone in osteogenic sarcoma cells is associated with activation of caspases
- (2014) SEOK-JIN YANG et al. ONCOLOGY REPORTS
- Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis
- (2014) Scott J Dixon et al. eLife
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
- (2012) Scott J. Dixon et al. CELL
- Osteosarcoma incidence and survival rates from 1973 to 2004
- (2009) Lisa Mirabello et al. CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started